The objective of this study is to explore the subject clinical profiles, procedural details and post-implant outcomes of patients who receive either the CanGaroo ECM Envelope or no envelope at the time of initial implantation.
Principal investigatorDr. John Ip, M.D., FACC
Trial CategoryHeart & Vascular
Trial SubCategoryAtrial Fibrillation